ACAleida Oliveira de Carvalho

Aleida Oliveira de Carvalho

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Aleida Oliveira de Carvalho has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Parentalidade Vulnerável: Pré-Natal Psicológico e Redução do Sofrimento Psíquico Materno na Pandemia

    by Aleida Oliveira de Carvalho, Alessandra da Rocha Arrais, Yácara Ribeiro Pereira, Lizandra Moura Paravidine Sasaki

    Resumo A pandemia colocou para todos a parentalidade em lugar vulnerável e gerou novos desafios para a vivência da perinatalidade e parentalidade para as mulheres. Este estudo trata-se de uma pesquisa-ação, transversal, de abordagem quantitativa e qualitativa, que apresentará os resultados da fase final da pesquisa, referentes à avaliação dos efeitos do Pré-natal Psicológico (PNP) na redução do sofrimento psíquico materno. Os resultados mostraram-se positivos quanto à eficácia do PNP na prevenção da depressão pós-parto e redução do sofrimento psíquico, no que tange às questões da perinatalidade e parentalidade, mesmo em período de pandemia.


  • Open Access

    Vulnerable Parenting: Psychological Prenatal Care and Reducing Maternal Psychological Distress During the Pandemic

    by Aleida Oliveira de Carvalho, Alessandra da Rocha Arrais, Yácara Ribeiro Pereira, Lizandra Moura Paravidine Sasaki

    The pandemic has put parenthood in a vulnerable place for everyone, generating new challenges for women's experience of perinatality and parenthood. This study is an action research, cross-sectional, with a quantitative and qualitative approach, which will present the results of the final phase of the research, referring to the evaluation of the effects of Psychological Prenatal Care (PNP) in reducing maternal psychological distress. The results were positive in terms of the effectiveness of PNP in preventing postpartum depression and reducing psychological distress with regard to perinatal and parenting issues, even during the pandemic.

  • Open Access

    Considerações sobre a Psicologia Perinatal em um ambulatório público de pré-natal especializado em gestantes expostas à COVID-19

    by Aleida Carvalho, Alessanda da Rocha Arrais

    INTRODUÇÃO: A COVID-19 surgiu com o imperativo urgente de construção de novos saberes e conhecimento científico. OBJETIVO: Diante dessa necessidade, este trabalho visa: relatar a experiência da psicologia perinatal, em um ambulatório público de pré-natal especializado em gestantes expostas à Covid-19 durante a gravidez; e discutir como essa experiência pode contribuir para a construção de intervenções em saúde mental voltadas para esse público durante a pandemia. MÉTODO: Trata-se de um relato de experiência. RESULTADOS: Pôde-se observar a presença de demandas circunscritas à própria perinatalidade e construção da parentalidade; relativas à pandemia, falta de informação precisa, adoecimento e sequelas físicas e emocionais provocadas pelo coronavírus. CONCLUSÃO: Esses achados permitem a psicologia, em especial ao campo da psicologia perinatal, adequar suas intervenções psicoterapêuticas e psicoeducativas às questões emergentes da pandemia. As estratégias precisam possibilitar a integração do cuidado, a ampliação do suporte social, emocional e instrumental para esse público, de modo, a possibilitar maior sensação de segurança frente à pandemia. Ressalta-se a necessidade de estudos que validem intervenções de saúde mental para gestantes durante a pandemia.


  • Open Access

    Pregnancy Outcomes and Child Development Effects of SARS-CoV-2 Infection (PROUDEST Trial): Protocol for a Multicenter, Prospective Cohort Study

    by Geraldo Magela Fernandes, Felipe Motta, Lizandra Moura Paravidine Sasaki, Ângelo Pereira Da Silva, Andreza Monforte Miranda, Aleida Oliveira De Carvalho, Ana Paula Monteiro Gomides, Alexandre Anderson De Sousa Munhoz Soares, Agenor De Castro Moreira Dos Santos Jr, Caroline De Oliveira Alves, et al.

    Background: A growing body of evidence suggests that SARS-COV-2 infection during pregnancy may affect maternal-fetal outcomes and possibly result in implications for the long-term development of SARS-CoV-2–exposed children. Objective: The PROUDEST (Pregnancy Outcomes and Child Development Effects of SARS-CoV-2 Infection Study) is a multicenter, prospective cohort study designed to elucidate the repercussions of COVID-19 for the global health of mothers and their children. Methods: The PROUDEST trial comprises 2 prospective, sequential substudies. The PREGNANT substudy will clinically assess the effects of SARS-CoV-2 infection on pregnancy, childbirth, and puerperium from a mechanistic standpoint to elucidate the pregnancy-related inflammatory and immunological phenomena underlying COVID-19. Pregnant women aged 18-40 years who have been exposed (proven with laboratory tests) to SARS-CoV-2 (group A; n=300) will be compared to control subjects with no laboratory evidence of in-pregnancy exposure to the virus (group B; n=300). Subjects exposed to other infections during pregnancy will be excluded. The BORN substudy is a long-term follow-up study that will assess the offspring of women who enrolled in the prior substudy. It will describe the effects of SARS-CoV-2 exposure during pregnancy on children’s growth, neurodevelopment, and metabolism from birth up to 5 years of age. It includes two comparison groups; group A (exposed; n=300) comprises children born from SARS-CoV-2–exposed pregnancies, and group B (controls; n=300) comprises children born from nonexposed mothers. Results: Recruitment began in July 2020, and as of January 2021, 260 pregnant women who were infected with SARS-CoV-2 during pregnancy and 160 newborns have been included in the study. Data analysis is scheduled to start after all data are collected. Conclusions: Upon completion of the study, we expect to have comprehensive data that will provide a better understanding of the effects of SARS-CoV-2 infection and related inflammatory and immunological processes on pregnancy, puerperium, and infancy. Our findings will inform clinical decisions regarding the care of SARS-CoV-2–exposed mothers and children and support the development of evidence-based public health policies. Trial Registration: Brazilian Register of Clinical Trials RBR65QXS2; https://ensaiosclinicos.gov.br/rg/RBR-65qxs2 International Registered Report Identifier (IRRID): DERR1-10.2196/26477